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Comparison of Effects of Sleeve gastrectomy, Duodenal-
jejunal Bypass and Ileal Transposition for Type II 
Diabetes
Daniel Tong; Kenneth K Lai; Nikki Lee; Kin Tak Chan; Simon 
Law
The University of Hong Kong, Hong Kong, Hong Kong
Introduction: Sleeve gastrectomy (SG), duodenal jejunal 
bypass (DJB) and ileal transposition (IT) have been reported 
to be effective for the treatment of T2DM. 
Objectives: It is unknown which procedure has a stronger 
anti-diabetic effect. The purpose of this study was to com-
pare the effectiveness of these novel procedures 
Methods: SG, DJB, IT and sham operation of each proced-
ure were performed in 10-12 weeks old Goto-Kakizaki rats, 
a spontaneous non-obese model of T2DM. The glucose 
homeostasis effect was evaluated by measuring fasting 
glucose (FBG) and glycosylated haemoglobin (HbA1c). Gut 
hormonal profiles and lipid absorption were also examined. 
Rats were observed for 1 year. 
Results: All three procedures had significant lower FBG 
when compared to the respective sham groups. DJB 
and IT had lower FBG than SG (SG vs DJB, p=0.023; SG vs 
IT, p=0.009) whereas DJB and IT had a similar FBG level, 
p=0.678. For HbA1c, all procedures had lower levels than 
the respective sham groups, p<0.001. The HbA1c of SG 
rebounded on 8th week whereas HbA1c of DJB and IT 
remained at low level. SG had a significant higher HbA1c 
level than DJB and IT, p<0.001 while DJB and IT had a similar 
level, p=0.685. 
GLP-1 and PYY were raised in DJB and IT whereas GIP level 
increased in DJB. All three procedures have different lipid 
absorption profile.
Conclusion: SG, DJB and IT all had anti-diabetic effect. DJB 
and IT had more potent anti-diabetic effect than SG. Each 
procedure has different effects on metabolic diseases and 
their clinic application deserve individual consideration. 
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Hormonal Changes in T2DM Patients Following Gastric 
Plication
Martin Fried1, 3 Karin Dolezalova1, 3 Petra Sramkova1, 2
1. OB Klinika Center for Treatment of Obesity and Metabolic Disorders, 
Prague, Czech Republic; 2. Endocrinology Institute, Prague, Czech 
Republic; 3. 1st Faculty of Medicine, Charles University, Prague, Czech 
Republic
Introduction: Laparoscopic Greater Curvature Plication 
(LGCP) is a relatively novel procedure. Since 2009 >1000 
LGCPs were performed in our institution. To our knowledge 
no study on incretin and other metabolic changes following 
LGCP is available yet. 
Objectives: To evaluate potential influence of LGCP on 
incretin and other metabolic parametres.
Methods: 23 obese T2diabetics (av. age: 54,4 ± 6,86 yrs; 
BMI: 40,1 ± 4,77 kg/m²) underwent meal test (375 kcal; 
protein 30%, carbohydrate 45%, fat 25%) before, 1 and 6 
mths after LGCP. Fasting blood samples and 30 min interval 
samples evaluations up to 3 hrs after meal test were done. 
Glycaemia, HbA1c, insulin, C-peptide, glukagon, HDL, LDL-
cholesterol, triacylglycerols, adipsin, adiponectin, ghrelin, 
GLP-1, GIP, leptin, PAI-1, resistin and visfatin were recorded. 
Results:  All pacients showed decrease in weight, BMI, 
waist-hip circumference (p<0,0001), % body fat (p<0,02), 
HbA1c and glycaemia(p<0,0001) 1mth after LGCP.
Postprandially insulin (p<0,0001), glucagon (p<0,03), 
resistin (p<0,007), leptin, ghrelin and PAI-1 (p<0,0001) de-
creased significantly. GIP, GLP-1 and visfatin didn´t change 
significantly 1mth after LGCP, however GIP (p<0,0001) and 
Adipsin (p<0,005) increased, on contrary with significantly 
decreased GLP-1 (p<0,05), and visfatin (p<0,005) 6 months 
postoperatively. 
Conclusion: T2 diabetics significantly decreased weight and 
other antropometry. Diabetes and lipid parametres signigfi-
cantly improved already 1 month after LGCP, and the trend 
continued with significance after 6 months. Significant 
decrease in insulin, glucagon, leptin, ghrelin, GLP-1, and 
increase in GIP and Adipsin was noted during follow-up. 
Results suggest that LGCP induces incretin and metabolic 
changes and is effective in treatment of obesity and T2DM 
in short to mid-term.
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Behavior of Glycemic Control (GC) after Laparoscopic 
Sleeve Gastrectomy (LSG) at 1 and 5 years in Morbidly 
Obese (MO) Indians
Shashank Shah1 Pallavi Shah1 Jayashri Gangwani1 Jayashree 
Todkar2 Gayatri Edake1 Poonam Shah1
1. laparoLaparo - Obeso Centreobeso centre, Pune, MH, India; 2. Ruby 
Hall clinic, Pune, MH, India
Introduction: LSG in MO is known to have improvement in 
Type 2 Diabetes (T2DM). However, long term results are still 
unknown.
Objectives: To evaluate long-term GC in MO Indians at 1 
and 5 years after LSG and its relation with weight and BMI.
Methods: Glycemic outcomes, weight and percentage 
Excess BMI Loss (%EBMIL) of 81 MO patients with T2DM who 
underwent LSG between January 2005 to January 2009 and 
had completed 1 and 5 year follow up were assessed and 
analyzed. Initially 41/81 were on oral hypoglycemic agents 
(OHA), 12/81 on OHA + insulin and 28/81 on metformin 
only. The baseline mean weight was 114.2 ± 27.30 kg, BMI 
43.6 ± 10.11 kg/m2 and duration of diabetes 5.2 years. Re-
mission was defined as HbA1c 6.5% and off medications.
Results: At 1 and 5 years after LSG 66/81, 58/81 had remis-
sion, 15/81, 23/81 improved and %EBMIL was 62.7%, 51.2%, 
the mean weight 80.5 ± 18.22, 89.07 ± 21.67 kg respectively. 
Recurrence of diabetes occurred in 8/66 (12%) patients who 
